# Catapult Ventures

> Catapult Ventures is a VC fund backing Health Care and Biotechnology. See 105 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Leicester, United Kingdom
- Total investments: 105
- Last investment: Nov 2024
- Lead investor: 25%
- Last fund: Jan 2018
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/catapult-venture-managers-limited
- Website: http://www.catapult-ventures.com

Catapult Ventures is a VC fund in Leicester focused on Health Care and Biotechnology. The team behind Catapult Ventures are among the most experienced venture capital investors in the UK.Their experience spans a range of sectors from healthcare and pharmaceuticals to luxury consumer brands, manufacturing and software, as well as all stages: from start-ups and pre-revenue IP developers to company floatation and billions of poundsin revenue. Their administration team is equally experienced with each member having more than 10 years experience in a venture capital environment.

## Contacts

5 contacts available for Catapult Ventures. Shizune tracks 9 team members at Catapult Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/catapult-venture-managers?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $150k–$5.6M |
| Series A | $1.6M–$26M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 25 | 24% |
| Biotechnology | 23 | 22% |
| Medical | 14 | 13% |
| Pharmaceutical | 14 | 13% |
| Software | 13 | 12% |

105 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Funding Round | 53 | 50% |
| Seed | 20 | 19% |
| Series A | 7 | 7% |
| Series B | 4 | 4% |
| Pre-Seed | 2 | 2% |

10 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United Kingdom | 71 | 68% |
| United States | 10 | 10% |
| Israel | 1 | 1% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Chris Spencer | Venture Partner | 0 | https://shizune.co/investors/profile/chris-spencer-2bb3 |
| Corinne Lawrence | Group Financial Controller | 0 | https://shizune.co/investors/profile/corinne-lawrence |
| David Whitcombe | Venture Partner | 0 | https://shizune.co/investors/profile/david-whitcombe-15de |
| David Whitcombe | Venture Partner | 0 | https://shizune.co/investors/profile/david-whitcombe |
| Duncan Cameron | Chief Financial Officer & Director | 0 | https://shizune.co/investors/profile/duncan-cameron |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Anello Photonics | Anello Photonics is a technology company developing a silicon photonic optical gyroscope to navigate, position, and motion track autonomous applications in challenging GPS-jammed and spoofed environments. The company's technology portfolio spans over 28 issued patents, and over 44 pending patents, and includes an AI-based sensor fusion engine.It serves the robotics, defense, construction, agriculture, and autonomous vehicles industries. |  | Series B | Nov 18, 2024 |  |
| Pickle Robot | Pickle Robot is a low cost, collaborative package handling robot that automates several key tasks along the e-commerce supply chain.Package handling is a physically demanding job with extremely high rates of turnover. The rising costs of shipping, comprised of 2/3rds labor, have become a major bottleneck to continued growth in e-commerce.Dill is the first robot from the Pickle Robot Company. It works multiple shifts, communicates with its human collaborators, and is rapidly developing new skills in handling e-commerce parcels: such as loading/unloading of feeder trucks, palletizing/depalletizing, and preloading of last mile delivery vans, trucks, and parcel cars. | $50M | Series B | Nov 11, 2024 |  |
| Path Robotics | Path Robotics designs robotic welding systems that incorporate AI and machine learning for enhanced precision and adaptability. These systems automate repetitive tasks, enabling manufacturers to increase productivity while minimizing upfront costs. The company addresses workforce challenges in the manufacturing sector through effective automationsolutions. | $100M | Series D | Oct 14, 2024 |  |
| CroBio | CroBio is a start-up founded by individuals specialising in microbiology and engineering. The company has a vision to create an environmentally sustainable solution to managing global agricultural drought.The companies current technology is based on a genetically engineered root-associated bacteria that has self-sustaining biologically activewater retention. The bacteria naturally occur around the roots of many crops such as corn, wheat and soybean. By exploiting these symbiotic relationships, we are able to engineer beneficial traits. | $1.6M | Seed | Apr 23, 2024 |  |
| Pencil Biosciences | Pencil Biosciences aims to develop a novel, programmable genome-modulation tool that overcomes the challenges associated with the technologies currently available. | $7.3M | Seed | Sep 28, 2023 |  |
| QV Bioelectronics | Time is precious and for patients with the most common brain tumour, glioblastoma, the value of that time really comes into focus when they are suddenly hit with the news there is no cure and that they have just one year to live. Current treatment options are not good enough and come at a huge cost to the quality of that remaining time. Ourco-founder Dr Richard Fu recognised this and was frustrated not only by the lack of treatments available for his brain tumour patients but also by major design flaws in newer electrotherapy approaches. Working together with Dr Chris Bullock, a biomedical engineer arising from Manchester's world-class materials research centres, they formed an elegant solution designed to optimise patient life-expectancy and quality of life. Together they formed QV Bioelectronics, and since then, their ground-breaking research has received over $425k in financial awards from several UK institutions, including Innovate UK and the National Institute for Health Research in the UK. The technology core patent has been filed, with full FTO. Additionally, alongside Dr Fu's expertise, the clinical advisory board contains some of Britain's top neurosurgeons who are helping to input into the feedback of the technology design. Our aim is to double patient life expectancy compared to standard treatment without impacting quality of life, so patients can focus on what matters. Join us at QV Bioelectronics, in pioneering a better option for terminal cancer patients. | $2.4M | Seed | Jan 10, 2023 |  |
| QV Bioelectronics | Time is precious and for patients with the most common brain tumour, glioblastoma, the value of that time really comes into focus when they are suddenly hit with the news there is no cure and that they have just one year to live. Current treatment options are not good enough and come at a huge cost to the quality of that remaining time. Ourco-founder Dr Richard Fu recognised this and was frustrated not only by the lack of treatments available for his brain tumour patients but also by major design flaws in newer electrotherapy approaches. Working together with Dr Chris Bullock, a biomedical engineer arising from Manchester's world-class materials research centres, they formed an elegant solution designed to optimise patient life-expectancy and quality of life. Together they formed QV Bioelectronics, and since then, their ground-breaking research has received over $425k in financial awards from several UK institutions, including Innovate UK and the National Institute for Health Research in the UK. The technology core patent has been filed, with full FTO. Additionally, alongside Dr Fu's expertise, the clinical advisory board contains some of Britain's top neurosurgeons who are helping to input into the feedback of the technology design. Our aim is to double patient life expectancy compared to standard treatment without impacting quality of life, so patients can focus on what matters. Join us at QV Bioelectronics, in pioneering a better option for terminal cancer patients. | $2.4M | Seed | Jan 10, 2023 |  |
| Urban Machine | Salvaging the past to build the future- Stealth Startup | $5.6M | Seed | Dec 08, 2022 |  |
| Pickle Robot | Pickle Robot is a low cost, collaborative package handling robot that automates several key tasks along the e-commerce supply chain.Package handling is a physically demanding job with extremely high rates of turnover. The rising costs of shipping, comprised of 2/3rds labor, have become a major bottleneck to continued growth in e-commerce.Dill is the first robot from the Pickle Robot Company. It works multiple shifts, communicates with its human collaborators, and is rapidly developing new skills in handling e-commerce parcels: such as loading/unloading of feeder trucks, palletizing/depalletizing, and preloading of last mile delivery vans, trucks, and parcel cars. | $26M | Series A | Nov 15, 2022 |  |
| Strella Biotechnology | Strella biotech is a revenue-generating food supply chain company that provides data to optimize the produce supply chain via patented proprietary sensing technology. It specializes in the fields of supply chain management and big data.Strella was founded in 2018 by Jacob Jordan and Katherine Sizov and is based in Philadelphia, Pennsylvania,United States. | $8M | Series A | Jun 07, 2022 |  |

10 of 105 investments shown.

## Co-investors
- [GM&C Life Sciences Fund](https://shizune.co/investors/profile/gm-c-life-sciences-fund) — VC Fund, 12 deals together
- [Midven](https://shizune.co/investors/profile/midven) — VC Fund, 5 deals together
- [Empirical Ventures](https://shizune.co/investors/profile/empirical-ventures) — VC Fund, 4 deals together
- [Nesta Ventures](https://shizune.co/investors/profile/nesta-investments) — VC Fund, 4 deals together
- [Oxford Capital](https://shizune.co/investors/profile/oxford-capital-partners) — VC Fund, 4 deals together
- [Ranpak](https://shizune.co/investors/profile/ranpak-holdings) — VC Fund, 4 deals together

## Similar investors

### Similar industry
- [SVG Ventures](https://shizune.co/investors/profile/svg-ventures) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Omnivore](https://shizune.co/investors/profile/omnivore-partners) — VC Fund

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

### Similar country
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [Fuel Ventures](https://shizune.co/investors/profile/fuel-ventures-fund) — VC Fund
- [Business Growth Fund](https://shizune.co/investors/profile/business-growth-fund) — VC Fund

## Featured in investor lists
- [Transportation Investors in United Kingdom](https://shizune.co/investors/transportation-investors-united-kingdom)
- [Transportation VC Funds in United Kingdom](https://shizune.co/investors/transportation-vc-funds-united-kingdom)
- [All Investors in United Kingdom](https://shizune.co/investors/investors-united-kingdom)
- [All VC Funds in United Kingdom](https://shizune.co/investors/vc-funds-united-kingdom)
- [Health Care Investors in United Kingdom](https://shizune.co/investors/health-care-investors-united-kingdom)
- [Health Care VC Funds in United Kingdom](https://shizune.co/investors/health-care-vc-funds-united-kingdom)

## FAQ

### What does Catapult Ventures invest in?

Catapult Ventures invests primarily in Health Care, Biotechnology and Medical startups, most often at Funding Round and Seed stage. Most of the 105 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Catapult Ventures's check size?

Catapult Ventures typically joins rounds of $150k–$5.6M at Seed and $1.6M–$26M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Catapult Ventures participates in.

### How do I contact Catapult Ventures?

Public channels for Catapult Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Catapult Ventures?

The team at Catapult Ventures includes Chris Spencer (Venture Partner), Corinne Lawrence (Group Financial Controller) and David Whitcombe (Venture Partner), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co